If you were pregnant in the last three years and have NEVER had COVID, you may be eligible to join the RECOVER study.
Looking for subjects between ages 60 years and 85 years to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in CDR-SB score as compared with placebo in participants with early Alzheimer's disease.
Research study participants will be randomized to exercise either in the morning or in the evening. Volunteers will receive a free 13-month exercise program and access to the Anschutz Health and Wellness Fitness Center.
You may qualify for this research study if you meet the following criteria:
• Adult between 18 and 55 years old
• Generally healthy without diabetes or heart disease
• Not currently exercising more than 150 minutes per week
• Overweight or Obese (BMI between 25.0 and 40.0 kg/m2)
• Do not regularly work overnight shifts
The criteria listed above is only a partial list of all the requirements to participate in this research study. Only a clinical research staff member can determine eligibility.
We are looking for volunteers to participate in a research study to receive a vaccine or placebo to help researchers learn more about how to prevent Respiratory Syncytial Virus (RSV) illness in infants and children. Your child can participate if they have a healthy immune system and have never had an illness caused by RSV.
Volunteers needed for a research study trying to learn more about sleep and insulin resistance (insulin not working) in teenagers, and how this may depend on sleep.
For people with prediabetes, it may be possible to delay or prevent the progression of diabetes by reducing postprandial glucose (PPG). Our Glycemic Excursion Minimization (GEM) lifestyle intervention guide can reduce PPG in people with type 2 diabetes. It has been studied in this population with continuous glucose monitor (CGM) feedback to help the user learn what elevates and lowers their PPG. This study examines if the GEM lifestyle intervention guide plus continuous input from the Libre 2 CGM will allow participants with prediabetes with A1c 6.0-6.4 to
1. Improve their metabolic status by illustrating the effects of their routine food and physical activity choices on their glucose levels and variability, more than Routine Care (RC)
2. Enhance these investigations by adding comprehensive plasma proteomics to the analyses
Research Admin Communications